The Influence of Obesity on Oocyte, Cumulus and Granulosa Functioning
NCT01945671 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2013-09-18
Summary
Obese women have a higher prevalence of infertility than their lean counterparts. Obesity is a risk factor for anovulation , including in response to gonadotropin treatment .Further, even in women who are cycling regularly, obesity is associated with increased time-to-pregnancy and decreased chance of natural pregnancy.
During obesity or periods of overnutrition, lipid accumulates in nonadipose tissues, notably skeletal muscle, liver, heart, and pancreas due to cellular uptake of exogenous fatty acids, triglycerides, and cholesterol as well as de novo lipogenesis in response to elevated glucose. The accumulation of intracellular lipid leads to high levels of free fatty acids that are subject to oxidative damage and the formation of cytotoxic and highly reactive lipid peroxides, which ultimately are detrimental to intracellular organelles, particularly the endoplasmic reticulum (ER) and mitochondria. Exposure of the ER to high levels of free fatty acids and lipid peroxides causes structural alterations that perturb ER function and lead to accumulation of unfolded proteins and calcium release. Failure of the UPR to reestablish ER homeostasis can lead to apoptosis .When mitochondria are exposed to high levels of free fatty acids, these can become oxidized by mitochondrial reactive oxygen species, forming lipid peroxides that damage essential proteins and uncouple mitochondrial function. This results in mitochondrial damage, which can cause further accumulation of lipids that cannot be catabolized, disrupted cellular homeostasis, and ultimately apoptosis .
The cellular mechanisms by which obesity causes decreased conception rates are not known. Based on extensive evidence of obesity-induced lipotoxicity in other cells, it was hypothesized that obesity results in the activation of lipotoxicity pathways in the ovary. It was shown that lipid accumulation, ER stress, mitochondrial dysfunction, and apoptosis occur in ovarian cells and the oocyte in response to a high-fat diet.
The aim of our study was to evaluate the influence of high BMI on oocytes, granulose cells and metabolites in the follicular fluid.
Conditions
- BMI
- Lipid Profile
Sponsors & Collaborators
-
Hillel Yaffe Medical Center
lead OTHER_GOV
Eligibility
- Min Age
- 20 Years
- Max Age
- 42 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-11-30
- Primary Completion
- 2015-01-31
- Completion
- 2015-05-31
More Related Trials
-
Reproductive Hormonal Alterations in Obesity
NCT01457703 ·Status: COMPLETED ·Phase: NA
-
Caloric Intake and Ovarian Reserve
NCT03604770 ·Status: WITHDRAWN
-
IR, Inflammatory and Cardiovascular Markers in PCOS Among Obese and Non-obese Women
NCT01989039 ·Status: UNKNOWN
-
Dietary Reversal of the Reprometabolic Syndrome
NCT07227766 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Anti-mullerian Hormone(AMH) Levels as a Predictive Factor of Response to Weight Loss Treatment in Obese Infertile Women With Poly Cystic Ovary(PCOS)
NCT01792362 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOS
NCT01482286 ·Status: TERMINATED ·Phase: PHASE3
-
Mediators of Abnormal Reproductive Function in Obesity (MARO)
NCT01817400 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A 6-month Observational Study on Combined Oral Contraceptives and Body Weight in Pre-Menopausal Women With Overweight or Obesity
NCT05061472 ·Status: COMPLETED
-
Adipose Expression of Leptin, Adiponectin and IL-6 and Plasma Levels of Adipocytokines in Women With and Without Polycystic Ovary Syndrome (PCOS)
NCT01088061 ·Status: COMPLETED
-
Weight Loss Intervention in Women With PCOS
NCT03677362 ·Status: COMPLETED ·Phase: NA
-
Age-related Changes in Ovarian Follicular Wave Dynamics
NCT01389141 ·Status: COMPLETED
-
Adipocytokines and Polycystic Ovary Syndrome (PCOS)
NCT00975832 ·Status: COMPLETED
-
Prevalence of Polycystic Ovary Syndrome (PCOS) in Obese Premenopausal Women
NCT01319162 ·Status: COMPLETED
-
The Secretion of Incretin Hormones in Patients With Polycystic Ovary Syndrome
NCT02126592 ·Status: UNKNOWN
-
Body Fat Distribution and Its Associated Factors in Chinese Women With Polycystic Ovary Syndrome
NCT04264832 ·Status: COMPLETED
-
Endocrine, Metabolic and Inflammatory Characteristics of Offspring of Mothers With PCOS Hyperandrogenism
NCT06371313 ·Status: COMPLETED
-
Multi-omics Analysis of Women With PCOS and Obesity Compared With Non-PCOS Obese Controls
NCT05468476 ·Status: COMPLETED
-
Activity of Chronic Inflammation in PCOS
NCT06300593 ·Status: COMPLETED
-
Effect of Hyperandrogenism on IVF Outcomes in PCOS Patients
NCT05555680 ·Status: TERMINATED
-
Stress Reduction for Overweight or Obese Women Either With Polycystic Ovary Syndrome (PCOS) or Without PCOS (Non-PCOS)
NCT01464398 ·Status: COMPLETED ·Phase: NA
-
Cluster Analysis of the Risk of Metabolic Syndrome in Women for Reproductive Age
NCT01826357 ·Status: UNKNOWN
-
THE ASSOCIATION BETWEEN FATTY LIVER (NAFLD) DISEASE AND PCOS
NCT01735799 ·Status: UNKNOWN
-
Nutritional and Metabolic Correlates of Ovarian Morphology in Women With Polycystic Ovary Syndrome
NCT01927471 ·Status: COMPLETED
-
EFFECT OF CRYOLIPOLYSIS ON HORMONAL PROFILE AND MENSTRUAL REGULARITYIN OBESE WITH PCOS
NCT06226701 ·Status: COMPLETED ·Phase: NA
-
Molecular Basis of PCOS in Oocytes and Surrounding Cells
NCT04493788 ·Status: UNKNOWN